Eric J. Roeland, MD, on Weight Gain and Overall Survival in Patients Treated for NSCLC

Eric J. Roeland, MD, of Oregon Health and Science University, Knight Cancer Institute, discusses study results showing that weight gain during treatment of patients with advanced non–small cell lung cancer (NSCLC) receiving first-line chemotherapy was associated with a reduced risk of death in both men and women, independent of smoking status.